Impact of initial surgical treatment on survival of patients with differentiated thyroid cancer: Experience of an endocrine surgery center in an iodine-deficient region

World Journal of Surgery

Volumn 24, Issue 11, 2000, Pages 1290-1294

  Duren, Mete ^a   Yavuz, Nihat ^a   Bukey, Yusuf ^a   Ozyegin, M Ates ^a   Gundogdu, Sadi ^a   Açbay, Ozer ^a   Hatemi, Husrey ^a   Uslu, Ihami ^a   Onsel, Çetin ^a   Aksoy, Figen ^a   Oz, Feriha ^a   Unal, Gurcan ^a   Duren, Erol ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Universal Hospitals Group   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; CANCER RECURRENCE; CANCER SURVIVAL; CONFERENCE PAPER; ENDOCRINE SURGERY; FEMALE; HUMAN; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; SUBTOTAL THYROIDECTOMY; SURGICAL TECHNIQUE; SURVIVAL TIME; THYROID CANCER; THYROID FOLLICLE CELL; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEFICIENCY DISEASES; ENDEMIC DISEASES; FEMALE; HUMANS; IODINE; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; SURGERY DEPARTMENT, HOSPITAL; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; TURKEY;

EID: 0033777544     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010214     Document Type: Conference Paper

References (50)

1. Evaluation and surgical treatment of papillary and follicular carcinoma
2. An expanded view of risk-group definition in differentiated thyroid carcinoma
3. Ipsilateral lobectomy versus bilateral resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system
4. A prognostic index for thyroid carcinoma: A study of the EORTC thyroid cancer cooperative group
5. Natural history, treatment, and course of papillary thyroid carcinoma
6. Papillary thyroid carcinoma: Factors influencing prognosis and current therapy
7. Feasibility of total thyroidectomy in the treatment of thyroid carcinoma: Post-operative radioactive iodine evaluation of 140 cases
8. Surgical management of papillary and follicular carcinoma of the thyroid
9. Serum thyroglobulin in benign thyroid diseases and thyroid malignancies
10. Current results of conservative surgery for differentiated thyroid carcinoma
11. Risk factor analysis in differentiated thyroid carcinoma
12. Thyroid cancer causing death after 40 years: Rationale for initial intensive treatment
13. Nonparametric estimation from incomplete observations
14. What do we need beyond TNM?
15. The use of radioactive iodine in thyroid carcinoma
16. Radioiodine therapy of malignant thyroid diseases
17. Surgical strategy for patients with recurrent carcinoma of the thyroid
18. Does the method of management of papillary thyroid carcinoma make a difference in outcome?
19. Unterschiedliche Strategien in Diagnostik und Therapie des Schilddrusenkarzinoms
20. Surgery of thyroid cancer
21. Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer
22. Management of the carcinoma of the thyroid
23. An analysis of the results of initial treatment
24. Thyroid nodules and thyroid cancer
25. Treatment of thyroid cancer in 293 patients
26. Total thyroidectomy for differentiated thyroid carcinoma: Primary and secondary operations
27. Follow-up of patients with differentiated thyroid carcinoma: Experience at Institut Gustave-Roussy
28. Papillary thyroid cancer treated at Mayo Clinic: 1946 through 1970; Initial manifestations, pathologic findings, therapy and outcome
29. Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients
30. Long term results and prognostic factors in patients with differentiated thyroid carcinoma
31. Prognostic features of thyroid cancer
32. Classification and prognosis of thyroid carcinoma
33. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients
34. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
35. Critical evaluation of serum thyroglobulin levels and I-131 scans in posttherapy patients with differentiated thyroid carcinoma: Concise communication
36. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer
37. The use of radioactive iodine in thyroid carcinoma
38. Distant metastases in papillary thyroid cancer: A review of 91 patients
39. Distant metastases in differentiated thyroid cancer: Long-term results of radioiodine treatment and statistical analysis of prognostic factors
40. Papillary and follicular thyroid cancer: Impact of treatment in 1,578 patients
41. Elective neck disection in papillary carcinoma of the thyroid
42. Papillary carcinoma of the thyroid: Clinical recurrence in the thyroid gland after initial surgical treatment
43. Therapeutic doses of iodine-131 reveal undiagnosed metastases in patients with detectable serum thyroglobulin levels
44. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer
45. Pulmonary metastases from differentiated thyroid carcinoma detected only by radionuclide imaging
46. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-rays
47. Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables
48. The endocrine dependency of certain thyroid cancers and the danger that hypothyroidism may stimulate their growth
49. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
50. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms